[Skip to Content]
[Skip to Content Landing]
Views 1,233
Citations 0
Invited Commentary
May 22, 2019

Prevention of Venous Thromboembolism in Colorectal Surgery With Enoxaparin: Are We Using the Right Dose?

Author Affiliations
  • 1Division of General and Gastrointestinal Surgery, Hospital Universitario Virgen de las Nieves, University of Granada, Granada, Spain
JAMA Surg. 2019;154(8):704-705. doi:10.1001/jamasurg.2019.1166

Patients undergoing colorectal surgery, particularly for cancer and inflammatory bowel disease, are at significant risk for postoperative venous thromboembolism (VTE), with reported rates between 2% and 9% despite prophylaxis.1 Recent guidelines recommend pharmacological prophylaxis with unfractionated heparin of low-molecular-weight heparins (LMWH) but do not provide specific recommendations about the optimal dosing.2

Limit 200 characters
Limit 25 characters
Conflicts of Interest Disclosure

Identify all potential conflicts of interest that might be relevant to your comment.

Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.

Err on the side of full disclosure.

If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.

Not all submitted comments are published. Please see our commenting policy for details.

Limit 140 characters
Limit 3600 characters or approximately 600 words
    ×